BioAge Labs, Inc.
BIOA
$4.17
-$0.03-0.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M |
| Total Depreciation and Amortization | 37.00K | 47.00K | 38.00K | 49.00K | 33.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.06M | 2.36M | 2.21M | 1.69M | 1.99M |
| Change in Net Operating Assets | -7.53M | 13.58M | 6.23M | -3.94M | -4.70M |
| Cash from Operations | -17.36M | -5.14M | -14.93M | -15.78M | -15.67M |
| Capital Expenditure | -426.00K | -26.00K | -305.00K | -35.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.56M | -- | -- | -- | -- |
| Cash from Investing | -77.99M | -26.00K | -305.00K | -35.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50M | -1.50M | -1.50M | -1.50M | -1.50M |
| Issuance of Common Stock | -- | 27.65M | 194.18M | 422.00K | 3.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 542.00K | -- | 170.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -40.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.24M | -2.54M | -1.27M | -502.00K |
| Cash from Financing | -1.50M | 24.90M | 190.68M | -2.39M | 168.00M |
| Foreign Exchange rate Adjustments | -12.00K | 137.00K | -58.00K | -17.00K | 19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.86M | 19.88M | 175.39M | -18.22M | 152.35M |